Recently published epidemiological and genetic studies strongly suggest a causal
relationship of elevated concentrations of lipoprotein (a)[Lp (a)] with cardiovascular disease …

Initially, lipoprotein (a)[Lp (a)] was believed to be a genetic variant of lipoprotein (Lp)-B.
Because its lipid moiety is almost identical to LDL, Lp (a) has been deliberately considered …

The serum lipoprotein Lp (a) concentration was measured in 76 male post-myocardial
infarction (MI) patients aged between 40 and 60 years, and in 107 control subjects of the …

Lp (a) is a plasma lipoprotein particle consisting of a plasminogenlike protein [apo (a)]
disulfide bonded to the apo B moiety of low-density lipoprotein (LDL). Increased plasma …

In a comprehensive study the concentrations of plasma lipids and lipo-and apolipoproteins
were measured in 24 nonpregnant women (control) and longitudinally in 42 women …

Abstract Lipoprotein (a)[Lp (a)] represents an LDL-like particle to which the Lp (a)-specific
apolipoprotein (a) is linked via a disulfide bridge. It has gained considerable interest as a …

The high affinity of human plasma β2‐glycoprotein I (β 2 GPI), also known as apolipoprotein‐
H (ApoH), for negatively charged phospholipids determines its implication in a variety of …

Abstract Lipoprotein (a)[Lp (a)] has been associated with both anti-fibrinolytic and
atherogenic effects. However, no direct link currently exists between this atherogenic …

In the present paper the influence of β 2-glycoprotein-I, also known as apolipoprotein H,
upon the prothrombinase activity of platelets and phospholipid vesicles was investigated …

An elevated concentration of lipoprotein (a)[Lp (a)] in the serum has been considered a risk
factor for coronary heart disease by various investigators. In the present study, the turnover …